E Kaputska

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Our original series of patients with prostatic carcinoma treated with irradiation as the initial modality has been updated. The over-all 5-year survival rate for patients with stage III carcinoma of the prostate was 55 per cent--26 per cent were alive with residual disease and have had post-irradiation hormone manipulation, while 29 per cent were alive(More)
  • 1